1 completed, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Post-polio Syndrome: new trials by email Literature Review of Post-polio Syndrome trials Research Report on Post-polio Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome Flebogamma® 5% DIF, Placebo - Post-polio Syndrome | Phase 2 / Phase 3 | Terminated | Instituto Grifols, S.A. | 191 | 2014-09-23 | 2025-12-05 |
| Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) IvIg - Post-Polio Syndrome | Phase 2 / Phase 3 | Completed | Haukeland University Hospital | 40 | 2003-08-01 | 2005-12-13 |
Postpoliomyelitis Syndrome (2)
Central Nervous System Diseases (2) · Central Nervous System Infections (2) · Enterovirus Infections (2) · Infections (2) · Muscular Diseases (2) · Muscular Disorders, Atrophic (2) · Musculoskeletal Diseases (2) · Myelitis (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neuroinflammatory Diseases (2) · Neuromuscular Diseases (2) · Picornaviridae Infections (2) · Poliomyelitis (2) · RNA Virus Infections (2)
Immunoglobulins, Intravenous (2) · gamma-Globulins (1)
Haukeland University Hospital (1) · Instituto Grifols, S.A. (1)
Canada (1) · Czechia (1) · Denmark (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · Spain (1) · United States (1)
Elisabeth Farbu, MD, PhD (1) · Marinos Dalakas, MD (1)